﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Renal Injury Prevention</JournalTitle>
      <Issn>2345-2781</Issn>
      <Volume>8</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2019</Year>
        <Month>03</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The therapeutic effect of autologous bone marrow mesenchymal stem cells to prevent the progress of chronic allograft nephropathy</ArticleTitle>
    <FirstPage>1</FirstPage>
    <LastPage>5</LastPage>
    <ELocationID EIdType="doi">10.15171/jrip.2019.01</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Gholami</LastName>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Ghasemi</LastName>
      </Author>
      <Author>
        <FirstName>Ahmad Reza</FirstName>
        <LastName>Bahrami</LastName>
      </Author>
      <Author>
        <FirstName>Hamid Reza</FirstName>
        <LastName>Bidkhouri</LastName>
      </Author>
      <Author>
        <FirstName>Hojat</FirstName>
        <LastName>Naderi Mishkin</LastName>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Pezeshki Rad</LastName>
      </Author>
      <Author>
        <FirstName>Farzaneh</FirstName>
        <LastName>Sharifipour</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/jrip.2019.01</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>02</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>07</Month>
        <Day>02</Day>
      </PubDate>
    </History>
    <Abstract>Progenitor cells or mesenchymal stem cells are new cells, with renovation and regeneration ability and tissues repair. In recent years, administration of stem cells has been introduced to treat a variety of diseases including chronic allograft injury (CAI). It seems that stem cells can create a turning point in regenerative medicine through repair, replacement with damaged tissues or with their paracrine effects.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Mesenchymal stem cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">End-stage renal disease</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chronic allograft nephropathy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chronic allograft injury</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Tubular atrophy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Interstitial fibrosis</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>